IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Incannex Healthcare Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$2.76−0.06 (-2.13%)
Close on Oct 19, 2026
- Market cap
- $33.89M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.6%
0M of 13M shares
Institutional holders
15
6 new, 11 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 900,000 | 7.00% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IXHL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| LPL Financial LLC | 148,178 | 1.18% | $557.15K | +77,000 | 0.00% |
| Millennium Management LLC | 95,252 | 0.76% | $358.15K | New | 0.00% |
| Jane Street Group, LLC | 78,195 | 0.62% | $294.01K | New | 0.00% |
| AdvisorShares Investments LLC | 60,868 | 0.49% | $228.86K | +36,365 | 0.03% |
| Susquehanna International Group, Llp | 28,771 | 0.23% | $108.18K | New | 0.00% |
| Commonwealth Equity Services, LLC | 14,029 | 0.11% | $52.75K | +1,917 | 0.00% |
| Citadel Advisors LLC | 10,349 | 0.08% | $38.91K | New | 0.00% |
| Osaic Holdings, Inc. | 6,376 | 0.05% | $23.97K | – | 0.00% |
| UBS Group AG | 3,610 | 0.03% | $13.57K | −36,759 | 0.00% |
| Morgan Stanley | 3,558 | 0.03% | $13.38K | +1,493 | 0.00% |
| Citigroup Inc | 2,814 | 0.02% | $10.58K | New | 0.00% |
| Quent Capital, LLC | 1,928 | 0.02% | $7.25K | – | 0.00% |
| Barclays PLC | 750 | 0.01% | $2.82K | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | 0.00% | $15 | New | 0.00% |
| Larson Financial Group LLC | 1 | 0.00% | $4 | −58 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 15 | 0M | 3.6% | 6 / 4 | 2 / 11 | 0M | 1M |
| Q1 2026 | 20 | 1M | 10.3% | 20 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IXHL | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 60,868 | 0.49% | $228.86K | 0.52% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 9,564 | 0.08% | $32.04K | 0.00% | May 31, 2026 |
| Total Stock Market Index Trust | 243 | 0.00% | $914 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -3,630 | -0.03% | -$13.65K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joel Latham | CEO and President, Director | 24,186,177 | 192.80% | Nov 14, 2025 |
| Joseph Swan | CFO, Treasurer and Secretary | 921,358 | 7.34% | Nov 14, 2025 |
| Luigi M. Barbato | Chief Medical Officer | 100,476 | 0.80% | Oct 24, 2024 |
| Robert Clark | Director | 1,786,956 | 14.24% | Nov 14, 2025 |
| Peter Widdows | Director | 1,957,803 | 15.61% | Nov 14, 2025 |
| Troy Valentine | Director | 12,339,120 | 98.36% | Nov 14, 2025 |
| George Anastassov | Director | 2,456,677 | 19.58% | Nov 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert Clark Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 1,786,956 |
| Peter Widdows Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 1,957,803 |
| Joel Latham CEO and President, Director | Nov 14, 2025 | Award | +22,608,692 | – | – | 24,186,177 |
| George Anastassov Director | Nov 14, 2025 | Award | +1,686,956 | – | – | 2,456,677 |
| Troy Valentine Director | Nov 14, 2025 | Award | +11,302,608 | – | – | 12,001,858 |
| Joseph Swan CFO, Treasurer and Secretary | Nov 14, 2025 | Award | +869,565 | – | – | 921,358 |
| Luigi M. Barbato Chief Medical Officer | Oct 23, 2024 | Award | +100,476 | – | – | 100,476 |
| Joseph Swan CFO, Treasurer and Secretary | May 6, 2024 | Award | +50,793 | – | – | 51,793 |
| Robert Clark Director | Dec 21, 2023 | Award | +100,000 | – | – | 100,000 |
| Peter Widdows Director | Dec 21, 2023 | Award | +100,000 | – | – | 270,847 |
| George Anastassov Director | Dec 21, 2023 | Award | +100,000 | – | – | 769,721 |
| Joel Latham CEO and President, Director | Dec 21, 2023 | Award | +1,340,000 | – | – | 1,577,485 |
| Troy Valentine Director | Dec 21, 2023 | Award | +670,000 | – | – | 699,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.